|
76
|
276
|
6y26A |
Crystal structure of hla-b2705 complexed with the nona-peptide ma |
|
71
|
278
|
7ji2A |
Crystal structure of h2-kb in complex with a ova mutant peptide |
|
70
|
276
|
7k80A |
Kir3dl1*001 in complex with hla-a*24:02 presenting the rypltfgw peptide |
|
75
|
276
|
6y29A |
Crystal structure of hla-b2709 complexed with the nona-peptide me |
|
80
|
276
|
6y27A |
Crystal structure of hla-b2709 complexed with the nona-peptide ma |
|
77
|
276
|
6uzqA |
Hla-b*15:01 complexed with a synthetic peptide |
|
79
|
276
|
6vb5A |
Hla-b*15:02 complexed with a synthetic peptide |
|
64
|
270
|
6lhhA |
Crystal structure of chicken 8mer-bf2*1501 |
|
78
|
276
|
6vb4A |
Hla-b*15:02 complexed with a synthetic peptide |
|
49
|
179
|
6wl3A |
Pretcrbeta-pmhc complex crystal structure |
|
78
|
276
|
6uzsA |
Hla-b*15:01 complexed with a synthetic peptide |
|
79
|
276
|
6vb6A |
Hla-b*15:02 complexed with a synthetic peptide |
|
51
|
178
|
6wl2A |
Pretcrbeta-pmhc complex crystal structure |
|
79
|
276
|
6vb0A |
Hla-b*15:02 complexed with a synthetic peptide |
|
77
|
276
|
6uzoA |
Hla-b*15:02 complexed with a synthetic peptide |
|
77
|
276
|
6vb7A |
Hla-b*15:02 complexed with a synthetic peptide |
|
72
|
277
|
6vb3A |
Hla-b*15:01 complexed with a synthetic peptide |
|
79
|
276
|
6uzpA |
Hla-b*15:01 complexed with a synthetic peptide |
|
71
|
275
|
6uz1A |
Noncanonical binding of single-chain a6 tcr variant s3-4 in complex with tax/hla-a2 |
|
78
|
276
|
6vb1A |
Hla-b*15:02 complexed with a synthetic peptide |
|
80
|
276
|
6vb2A |
Hla-b*15:02 complexed with a synthetic peptide |
|
76
|
276
|
6y2aA |
Crystal structure of hla-b2705 complexed with the nona-peptide mq |
|
78
|
276
|
6uznA |
Hla-b*15:02 complexed with a synthetic peptide |
|
78
|
276
|
6viuA |
Hla-b*15:02 complexed with a synthetic peptide |
|
79
|
276
|
6uzmA |
Hla-b*15:02 complexed with a synthetic peptide |
|
80
|
278
|
7kgpA |
Crystal structure of hla-a*0201 in complex with sars-cov-2 n316-324 |
|
78
|
278
|
7kgtA |
Crystal structure of hla-a*0201 in complex with sars-cov-2 n226-234 |
|
75
|
276
|
7kgqA |
Crystal structure of hla-a*0201in complex with sars-cov-2 n222-230 |
|
75
|
274
|
7kgrA |
Crystal structure of hla-a*0201in complex with sars-cov-2 n159-167 |
|
78
|
278
|
7kgsA |
Crystal structure of hla-a*0201 in complex with sars-cov-2 n138-146 |
|
77
|
275
|
7kgoA |
Crystal structure of hla-a*0201in complex with sars-cov-2 n351-359 |
|
62
|
269
|
6xqpA |
Structure of human d462-e4 tcr in complex with human mr1-5-op-ru |
|
64
|
275
|
7cjqA |
Struture of dla-88*001:01 |
|
67
|
274
|
6jq3A |
Crystal structure of h2-kb in complex with a dpagt1 mutant peptide |
|
80
|
275
|
6vr1A |
Complex of hla-a2, a class i mhc, with a p53 peptide |
|
81
|
274
|
6vrnA |
T cell receptor-p53-hla-a2 complex |
|
79
|
274
|
6vr5A |
Complex of hla-a2, a class i mhc, with a p53 peptide |
|
70
|
273
|
6vrmA |
T cell receptor-p53-hla-a2 complex |
|
68
|
273
|
6vqoA |
T cell receptor-p53-hla-a2 complex |
|
78
|
275
|
6v3jA |
Kir3dl1 in complex with hla-b*57:03 presenting the peptide lsspvtksf |
|
78
|
276
|
6v2oA |
Hla-b*57:01 presenting the peptide aslnlpavsw |
|
79
|
276
|
6v2pA |
Hla-b*57:03 presenting the peptide aslnlpavsw |
|
78
|
276
|
6v2qA |
Hla-b*57:03 presenting the peptide lsspvtksf |
|
62
|
273
|
6uonA |
Molecular basis for tumor infiltrating tcr recognition of hotspot kras-g12d mutation |
|
61
|
272
|
6ulrA |
Molecular basis for tumor infiltrating tcr recognition of hotspot kras-g12d mutation |
|
73
|
273
|
6ulnA |
Molecular basis for tumor infiltrating tcr recognition of hotspot kras-g12d mutation |
|
73
|
273
|
6ulkA |
Molecular basis for tumor infiltrating tcr recognition of hotspot kras-g12d mutation |
|
74
|
273
|
6uliA |
Molecular basis for tumor infiltrating tcr recognition of hotspot kras-g12d mutation |
|
71
|
276
|
6ss8A |
Human leukocyte antigen class i a02 carrying llwngpiav |
|
70
|
276
|
6ss9A |
Human leukocyte antigen class i a02 carrying llwngpmhv |
